These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9456659)

  • 21. Neutrophils from human immunodeficiency virus (HIV)-seronegative donors induce HIV replication from HIV-infected patients' mononuclear cells and cell lines: an in vitro model of HIV transmission facilitated by Chlamydia trachomatis.
    Ho JL; He S; Hu A; Geng J; Basile FG; Almeida MG; Saito AY; Laurence J; Johnson WD
    J Exp Med; 1995 Apr; 181(4):1493-505. PubMed ID: 7699332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of detection of human immunodeficiency virus type 1 in the saliva of infected children and adolescents.
    Melvin AJ; Tamura GS; House JK; Hobson AC; Cone RW; Frenkel LM; Burchett S
    Arch Pediatr Adolesc Med; 1997 Mar; 151(3):228-32. PubMed ID: 9080928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Saliva inhibits HIV-1 infectivity.
    Fox PC; Wolff A; Yeh CK; Atkinson JC; Baum BJ
    J Am Dent Assoc; 1988 May; 116(6):635-7. PubMed ID: 3164028
    [No Abstract]   [Full Text] [Related]  

  • 24. Salivary gland disease in human immunodeficiency virus-positive women from the WIHS study. Women's Interagency HIV Study.
    Mulligan R; Navazesh M; Komaroff E; Greenspan D; Redford M; Alves M; Phelan J
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Jun; 89(6):702-9. PubMed ID: 10846124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
    BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
    J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of crude human saliva and purified salivary MUC5B and MUC7 mucins in the inhibition of Human Immunodeficiency Virus type 1 in an inhibition assay.
    Habte HH; Mall AS; de Beer C; Lotz ZE; Kahn D
    Virol J; 2006 Nov; 3():99. PubMed ID: 17125499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The anti-HIV-1 activity associated with saliva.
    Shine N; Konopka K; Düzgüneş N
    J Dent Res; 1997 Feb; 76(2):634-40. PubMed ID: 9062556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of human immunodeficiency virus type 1-specific inhibitory activities in saliva and other human mucosal fluids.
    Kazmi SH; Naglik JR; Sweet SP; Evans RW; O'Shea S; Banatvala JE; Challacombe SJ
    Clin Vaccine Immunol; 2006 Oct; 13(10):1111-8. PubMed ID: 16928883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel soluble mimic of the glycolipid, globotriaosyl ceramide inhibits HIV infection.
    Lund N; Branch DR; Mylvaganam M; Chark D; Ma XZ; Sakac D; Binnington B; Fantini J; Puri A; Blumenthal R; Lingwood CA
    AIDS; 2006 Feb; 20(3):333-43. PubMed ID: 16439866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced HIV infectivity and changes in GP120 conformation associated with viral incorporation of human leucocyte antigen class I molecules.
    Cosma A; Blanc D; Braun J; Quillent C; Barassi C; Moog C; Klasen S; Spire B; Scarlatti G; Pesenti E; Siccardi AG; Beretta A
    AIDS; 1999 Oct; 13(15):2033-42. PubMed ID: 10546855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV type 1-specific IgE in serum of long-term surviving children inhibits HIV type 1 production in vitro.
    Pellegrino MG; Bluth MH; Smith-Norowitz T; Fikrig S; Volsky DJ; Moallem H; Auci DL; Nowakowski M; Durkin HG
    AIDS Res Hum Retroviruses; 2002 Mar; 18(5):363-72. PubMed ID: 11897038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Superiority of infectivity-based over particle-based methods for quantitation of drug resistant HIV-1 as inocula for cell cultures.
    Tschochner M; Schwingel E; Thein C; Wittmann S; Paatz C; Walter H
    J Virol Methods; 2007 Apr; 141(1):87-96. PubMed ID: 17196267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TLR7 Agonist GS-9620 Is a Potent Inhibitor of Acute HIV-1 Infection in Human Peripheral Blood Mononuclear Cells.
    Bam RA; Hansen D; Irrinki A; Mulato A; Jones GS; Hesselgesser J; Frey CR; Cihlar T; Yant SR
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abortive infection in HeLaCD4 cells by a primary HIV type 1 isolate: implications for differential host cell tropism.
    Smyth RJ; Yi Y; Kim FM; Collman RG
    AIDS Res Hum Retroviruses; 1997 Jun; 13(9):759-69. PubMed ID: 9171220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tropism-restricted neutralization by secretory IgA from parotid saliva of HIV type 1-infected individuals.
    Wu X; Hall S; Jackson S
    AIDS Res Hum Retroviruses; 2003 Apr; 19(4):275-81. PubMed ID: 12804003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of in vitro and in vivo infectivity of different clade B HIV-1 envelope chimeric simian/human immunodeficiency viruses in Macaca mulatta.
    Bogers WM; Dubbes R; ten Haaft P; Niphuis H; Cheng-Mayer C; Stahl-Hennig C; Hunsmann G; Kuwata T; Hayami M; Jones S; Ranjbar S; Almond N; Stott J; Rosenwirth B; Heeney JL
    Virology; 1997 Sep; 236(1):110-7. PubMed ID: 9299623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salivary inhibition of HIV-1 infectivity: functional properties and distribution in men, women, and children.
    Fox PC; Wolff A; Yeh CK; Atkinson JC; Baum BJ
    J Am Dent Assoc; 1989 Jun; 118(6):709-11. PubMed ID: 2738248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD4 antigen-based antireceptor peptides inhibit infectivity of human immunodeficiency virus in vitro at multiple stages of the viral life cycle.
    Nara PL; Hwang KM; Rausch DM; Lifson JD; Eiden LE
    Proc Natl Acad Sci U S A; 1989 Sep; 86(18):7139-43. PubMed ID: 2789382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salivary gland involvement in HIV-1 infection.
    Fox PC
    Oral Surg Oral Med Oral Pathol; 1992 Feb; 73(2):168-70. PubMed ID: 1549311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells.
    Offersen R; Nissen SK; Rasmussen TA; Østergaard L; Denton PW; Søgaard OS; Tolstrup M
    J Virol; 2016 May; 90(9):4441-4453. PubMed ID: 26889036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.